AVAH:NSD-Aveanna Healthcare Holdings Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 4.48

Change

-0.10 (-2.18)%

Market Cap

USD 1.04B

Volume

0.12M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-23 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

-0.74 (-0.55%)

USD 8.25B
OPCH Option Care Health Inc

+0.01 (+0.04%)

USD 4.00B
ACHC Acadia Healthcare Company Inc

-0.40 (-1.06%)

USD 3.78B
AMED Amedisys Inc

+0.60 (+0.71%)

USD 2.81B
LFST Lifestance Health Group Inc

-0.03 (-0.41%)

USD 2.74B
SGRY Surgery Partners Inc

-0.12 (-0.57%)

USD 2.59B
ADUS Addus HomeCare Corporation

-2.54 (-1.93%)

USD 2.27B
ASTH Astrana Health Inc

-0.23 (-0.68%)

USD 1.89B
HCSG Healthcare Services Group Inc

-0.18 (-1.59%)

USD 0.91B
CCRN Cross Country Healthcare Inc

-0.01 (-0.06%)

USD 0.58B

ETFs Containing AVAH

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 67.16% 96% N/A 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 67.16% 96% N/A 90% A-
Trailing 12 Months  
Capital Gain 64.10% 96% N/A 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 64.10% 96% N/A 89% A-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 23.02% 67% D+ 76% C+
Dividend Return 23.02% 67% D+ 75% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 107.22% 26% F 20% F
Risk Adjusted Return 21.47% 63% D 55% F
Market Capitalization 1.04B 68% D+ 71% C-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector